Kenvue vs Restream
Side-by-side comparison of AI visibility scores, market position, and capabilities
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
Austin multi-streaming platform broadcasting live video to 30+ destinations including Twitch, YouTube, and Facebook Live simultaneously; trusted by creators, media companies, and businesses.
About
Restream is an Austin-based live streaming company that provides multi-stream broadcasting technology enabling content creators, businesses, and media companies to broadcast live video simultaneously to over 30 streaming destinations including Twitch, YouTube, Facebook Live, LinkedIn Live, and custom RTMP destinations from a single source. The platform eliminates the need to choose a single streaming platform by enabling simultaneous multi-destination broadcasting, maximizing audience reach across wherever viewers are watching. Restream also provides a browser-based live studio for creating professional broadcasts without dedicated streaming hardware, including overlays, lower-thirds, guest invitations, and screen sharing. The company serves a broad range of users from gaming streamers and podcasters to corporate communications teams running product launches and all-hands meetings. Founded in 2015 in Kyiv with operations in Austin, Restream has grown to serve millions of streamers globally. The company raised over $50M from investors including Bessemer Venture Partners and competes with StreamYard, OBS, and Wirecast in the live streaming software market.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.